Carlyle Asia

Carlyle Asia is the regional private equity division of The Carlyle Group, a global investment firm with a significant presence in the healthcare and life sciences sectors. The firm focuses on buyouts and growth capital investments across the Asia-Pacific region, targeting high-growth companies in pharmaceuticals, biotechnology, medical devices, and healthcare services. Carlyle Asia utilizes its extensive global network and deep sector expertise to help portfolio companies scale operations and improve clinical outcomes. Notable healthcare investments in the region include Adicon Clinical Laboratories, HCP Packaging, and Salubris Biotherapeutics. The firm is one of the most active private equity investors in the Asian healthcare market, maintaining dedicated teams in major hubs like Hong Kong, Shanghai, and Mumbai.